H1 Blog

AUGUST 17, 2023

An HCP Digital Engagement Strategy Case Study In this case study , H1 partnered with a top global pharma company to enable them to expand their digital engagement strategies beyond traditional KOLs to deliver effective messaging related to patient care while also staying compliant with healthcare regulations – making it easier than ever before to keep (..)

Pharma Companies 52

Pharma Companies Regulations Treatment Research 52

H1 Blog

DECEMBER 11, 2024

In 2025, I predict that there will be global regulations requiring comprehensive diversity plans for all major markets, including the EU and EMEA. As these standards take shape, pharma companies will adopt tools and models to reach broader and more diverse participants.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

Advarra

JULY 19, 2022

The standard for the audit used depends on the type of vendor and would include the applicable regulations and ICH guidelines. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval. The term drug substance and drug product are found in the NDA regulations 21 CFR 314.3,

Packaging 52

Packaging FDA Trials Regulations 52

The Pharma Data

DECEMBER 17, 2020

AB2 Bio – Swiss pharma company AB2 Bio Ltd. holding positions of increasing responsibility in Merck Research Laboratories before joining the company’s executive committee as CSO. Immune Regulation – U.K.-based based Immune Regulation Ltd. named Djordje Filipovic as its new chief commercial officer.

Small Molecule 52

Small Molecule Clinical Development Engineering Pharmaceuticals 52

Altus Drug Development

JUNE 28, 2022

For instance, European pediatric regulation places certain requirements to support the safety and efficacy of drugs destined to be used on children ( source ). In an effort to reduce regulatory risk and reach the market faster, pharma companies might decide to pursue the approval of medicines with a simple lead formulation.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

NOVEMBER 5, 2020

The demand for an effective drug for nail fungus is high and MOB-015 can achieve a unique market position through its high antifungal effect,” says Anna Ljung, CEO of Moberg Pharma. The information was submitted for publication, through the agency of the contact persons set out above, at 8.00 CET on November 6, 2020.

Marketing 40

Marketing Production Regulations Pharma Companies 40

Codon

FEBRUARY 13, 2024

Regulators traditionally want to see a single, stable, well-characterized drug before giving the green light for it to be tested in a clinical trial, not dozens of different viruses; let alone ones that are best found in unappealing places like sewage , hospital waste, or bird poop.

Therapies 135

Therapies Virus DNA Clinical Trials 135

The Pharma Data

MAY 14, 2021

First, most are on the payroll of the big pharma companies earning lucrative commissions for pushing their drugs…. While most of the focus is on the pancreas, as that’s the organ that produces insulin and plays a major role in regulating erratic blood levels…. The second reason is even more common….

Doctors 52

Doctors Production Medical Schools Pharma Companies 52

The Anticancer Fund

JUNE 7, 2022

Also notable is that the majority of the new use patents are held by pharma companies, and that they maintain (pay to renew) their portfolio. Clinical investigation of this approach, particularly with respect to the sequencing of chemotherapy and immunotherapy, is warranted.

Drugs 40

Drugs Clinical Trials Trials Treatment 40

Agency IQ

JULY 12, 2024

BY LAURA DIANGELO, MPH | JUL 10, 2024 3:47 PM CDT Regulatory background: The FDA is responsible for overseeing information about regulated products. The FDA is responsible for ensuring that medical products are adequately labeled in accordance with federal regulations, including the product’s “intended use” and relevant safety information.

FDA 40

FDA Regulations Production Science 40

Drug Patent Watch

APRIL 8, 2025

"5 Key Considerations for Valuing Pharma Companies As the pharmaceutical industry continues to evolve, accurately valuing pharma companies has become increasingly complex. Patent Portfolio Strength : A strong patent portfolio can significantly impact a company's valuation.

Pharma Companies 89

Pharma Companies Biosimilars Pharmaceuticals Regulations 89

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. Carl was taking ibuprofen and opiates to manage the pain, but knew he had to be careful to regulate it because of the kidney and liver problems it could cause. It’s all about the bottom line, at any cost.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

Drug Target Review

MARCH 13, 2025

The journey from distrust to collaboration among industry, academia and regulators will expedite integration, minimise clinical failures and enhance economic sustainability. Techbio companies have initiated this approach. FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine.

Drug Development 59

Drug Development Science Clinical Trials FDA 59

The Pharma Data

DECEMBER 30, 2020

The reason for this is still not understood and many regulators may want it to be explained before authorizing it for broader use. One of the reasons they expect VC spending in biopharma to expand is that during 2020, particularly from March through about July, many pharma companies, if able, paused their clinical trials.

Vaccine 52

Vaccine FDA Trials Therapies 52

The Pharma Data

DECEMBER 16, 2020

Recombinant monoclonal antibodies are designed to enhance the immune system’s ability to regulate cell functions. and will leverage a major COVID-19 vaccine partnership the company struck with the U.K. Defense Advanced Research Projects Agency (DARPA), as well as previous funding from the Bill and Melinda Gates Foundation.

Vaccine 52

Vaccine DNA Government Pharma Companies 52

Drug & Device Law

APRIL 7, 2023

The company lodged a request under the Freedom of Information Act (“FOIA”), which the FDA refused. So the company sued, and the district judge ruled that the FDA had no valid basis to withhold the requested information. The company therefore submitted a supplemental New Drug Application, or sNDA, seeking approval for that use.

FDA 64

FDA Government Pharma Companies Regulations 64